title: Vaccination of allogeneic hematopoietic stem cell transplant recipients-what should be considered?
authors.affiliation: Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie, Universitätsklinikum Jena, Am Klinikum 1, D- 07740, Jena, Germany. inken.hilgendorf@med.uni-jena.de.
authors.forename: Inken
authors.identifier: 0000-0003-2038-9730
authors.initials: I
authors.lastname: Hilgendorf
authors.affiliation: Division of Hematology, Medical University of Graz, Graz, Austria.
authors.forename: Hildegard
authors.initials: H
authors.lastname: Greinix
authors.affiliation: Internal Medicine, Department of Hematology, University Hospital of Basel, Basel, Switzerland.
authors.forename: Jörg
authors.initials: J
authors.lastname: Halter
authors.affiliation: St. Anna Children's Hospital, Medical University Vienna, Vienna, Austria.
authors.forename: Anita
authors.initials: A
authors.lastname: Lawitschka
authors.affiliation: Department of Internal Medicine III, Haematology and Oncology, University Medical Center of Regensburg, Regensburg, Germany.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wolff
mesh_terms: D003141:Communicable Diseases; D006086:Graft vs Host Disease; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D014611:Vaccination